Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hnf4g
|
ENSMUSG00000017688.8 | hepatocyte nuclear factor 4, gamma |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr3_3634201_3634368 | Hnf4g | 134 | 0.975634 | 0.19 | 1.5e-01 | Click! |
chr3_3638049_3638200 | Hnf4g | 3974 | 0.316198 | 0.16 | 2.1e-01 | Click! |
chr3_3634582_3634832 | Hnf4g | 557 | 0.838426 | 0.12 | 3.6e-01 | Click! |
chr3_3637227_3637418 | Hnf4g | 3172 | 0.342306 | 0.11 | 4.0e-01 | Click! |
chr3_3508502_3508830 | Hnf4g | 636 | 0.774187 | 0.11 | 4.1e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_129216664_129219042 | 9.78 |
Pitx2 |
paired-like homeodomain transcription factor 2 |
3578 |
0.2 |
chr7_142662290_142664788 | 9.14 |
Igf2os |
insulin-like growth factor 2, opposite strand |
1599 |
0.21 |
chr11_85838795_85841602 | 9.02 |
Tbx2 |
T-box 2 |
7647 |
0.13 |
chr1_162217585_162219370 | 8.70 |
Dnm3os |
dynamin 3, opposite strand |
601 |
0.46 |
chr12_9573836_9576858 | 8.03 |
Osr1 |
odd-skipped related transcription factor 1 |
906 |
0.56 |
chr5_119673827_119675890 | 7.98 |
Tbx3 |
T-box 3 |
587 |
0.67 |
chr2_9882196_9886301 | 7.87 |
9230102O04Rik |
RIKEN cDNA 9230102O04 gene |
255 |
0.84 |
chr7_142576289_142578620 | 7.70 |
H19 |
H19, imprinted maternally expressed transcript |
68 |
0.78 |
chr7_142660049_142661342 | 7.51 |
Igf2 |
insulin-like growth factor 2 |
510 |
0.56 |
chr17_67949642_67951057 | 7.32 |
Arhgap28 |
Rho GTPase activating protein 28 |
591 |
0.83 |
chr5_119669544_119672401 | 7.20 |
Tbx3 |
T-box 3 |
46 |
0.85 |
chr5_134945425_134947032 | 7.18 |
Cldn4 |
claudin 4 |
706 |
0.44 |
chr13_55825087_55826711 | 6.95 |
Gm47071 |
predicted gene, 47071 |
351 |
0.82 |
chr7_142654280_142656231 | 6.65 |
Mir483 |
microRNA 483 |
259 |
0.76 |
chr18_75384437_75388058 | 6.58 |
Smad7 |
SMAD family member 7 |
11333 |
0.21 |
chr18_61045132_61047010 | 6.37 |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
871 |
0.5 |
chr8_121088119_121090419 | 6.08 |
Gm27530 |
predicted gene, 27530 |
4563 |
0.13 |
chr5_37826544_37829286 | 6.06 |
Msx1 |
msh homeobox 1 |
3332 |
0.25 |
chr2_174283563_174287177 | 6.01 |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
12 |
0.53 |
chr2_84634714_84636973 | 6.00 |
Ctnnd1 |
catenin (cadherin associated protein), delta 1 |
2262 |
0.17 |
chr18_60646910_60648302 | 5.98 |
Synpo |
synaptopodin |
666 |
0.69 |
chr11_85889787_85891444 | 5.90 |
Tbx4 |
T-box 4 |
552 |
0.75 |
chr9_45042261_45043690 | 5.89 |
Mpzl2 |
myelin protein zero-like 2 |
279 |
0.8 |
chr9_24769617_24771807 | 5.86 |
Tbx20 |
T-box 20 |
962 |
0.56 |
chr11_97439854_97442222 | 5.86 |
Arhgap23 |
Rho GTPase activating protein 23 |
4753 |
0.18 |
chr12_117657998_117660727 | 5.79 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
1328 |
0.51 |
chr8_121082801_121085531 | 5.78 |
Foxf1 |
forkhead box F1 |
220 |
0.71 |
chr11_99043636_99045890 | 5.71 |
Igfbp4 |
insulin-like growth factor binding protein 4 |
3 |
0.96 |
chr5_30913519_30915234 | 5.68 |
Emilin1 |
elastin microfibril interfacer 1 |
637 |
0.48 |
chr2_27887830_27888871 | 5.64 |
2810430I11Rik |
RIKEN cDNA 2810430I11 gene |
1298 |
0.42 |
chr4_138967157_138968486 | 5.60 |
Rnf186 |
ring finger protein 186 |
709 |
0.62 |
chr11_85833878_85836704 | 5.50 |
Tbx2 |
T-box 2 |
2740 |
0.17 |
chr5_21543417_21545108 | 5.39 |
Lrrc17 |
leucine rich repeat containing 17 |
699 |
0.68 |
chr17_85686512_85689764 | 5.38 |
Six2 |
sine oculis-related homeobox 2 |
116 |
0.96 |
chr12_33966605_33968831 | 5.36 |
Twist1 |
twist basic helix-loop-helix transcription factor 1 |
10047 |
0.22 |
chr8_70493071_70496051 | 5.34 |
Crlf1 |
cytokine receptor-like factor 1 |
1200 |
0.25 |
chr2_105125289_105128976 | 5.21 |
Wt1 |
Wilms tumor 1 homolog |
78 |
0.91 |
chr5_75148315_75152589 | 5.19 |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
1840 |
0.2 |
chr1_136945385_136947968 | 5.18 |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
2497 |
0.34 |
chr5_37818003_37820431 | 5.16 |
Msx1 |
msh homeobox 1 |
5365 |
0.21 |
chr8_121127806_121129187 | 5.16 |
Foxl1 |
forkhead box L1 |
556 |
0.66 |
chr8_121118797_121121438 | 5.09 |
Foxc2 |
forkhead box C2 |
3946 |
0.14 |
chr11_85885788_85887022 | 5.09 |
Tbx4 |
T-box 4 |
17 |
0.97 |
chr12_57538344_57540173 | 5.07 |
Foxa1 |
forkhead box A1 |
6863 |
0.16 |
chr3_99255907_99257438 | 4.99 |
Tbx15 |
T-box 15 |
2912 |
0.22 |
chr8_57320946_57324000 | 4.97 |
Hand2os1 |
Hand2, opposite strand 1 |
1245 |
0.3 |
chr2_157456825_157458020 | 4.95 |
Src |
Rous sarcoma oncogene |
337 |
0.88 |
chr13_55827549_55829422 | 4.92 |
Gm47071 |
predicted gene, 47071 |
2235 |
0.21 |
chr16_92693730_92694957 | 4.86 |
Runx1 |
runt related transcription factor 1 |
1152 |
0.59 |
chr15_35295781_35297332 | 4.84 |
Osr2 |
odd-skipped related 2 |
445 |
0.83 |
chr8_107545084_107547731 | 4.83 |
Wwp2 |
WW domain containing E3 ubiquitin protein ligase 2 |
1395 |
0.4 |
chr3_66977838_66980287 | 4.82 |
Shox2 |
short stature homeobox 2 |
251 |
0.9 |
chr8_57324709_57326732 | 4.73 |
Hand2os1 |
Hand2, opposite strand 1 |
1487 |
0.3 |
chr3_84189998_84191469 | 4.68 |
Trim2 |
tripartite motif-containing 2 |
210 |
0.94 |
chr4_114901229_114903111 | 4.65 |
9130410C08Rik |
RIKEN cDNA 9130410C08 gene |
689 |
0.59 |
chr2_146834060_146838027 | 4.63 |
Gm14114 |
predicted gene 14114 |
3689 |
0.27 |
chr13_55835316_55837389 | 4.63 |
Pitx1 |
paired-like homeodomain transcription factor 1 |
160 |
0.62 |
chr12_9578132_9580204 | 4.62 |
Osr1 |
odd-skipped related transcription factor 1 |
4727 |
0.2 |
chr14_63244119_63245953 | 4.59 |
Gata4 |
GATA binding protein 4 |
212 |
0.93 |
chrX_52610922_52611739 | 4.57 |
Gpc3 |
glypican 3 |
2591 |
0.28 |
chr8_122431840_122432911 | 4.56 |
Cyba |
cytochrome b-245, alpha polypeptide |
530 |
0.58 |
chr7_29124042_29125535 | 4.51 |
Ryr1 |
ryanodine receptor 1, skeletal muscle |
227 |
0.84 |
chr13_63557270_63560459 | 4.50 |
Ptch1 |
patched 1 |
4951 |
0.16 |
chr12_73545329_73546631 | 4.47 |
Tmem30b |
transmembrane protein 30B |
412 |
0.8 |
chr5_119676129_119676716 | 4.47 |
Tbx3 |
T-box 3 |
977 |
0.47 |
chr9_114560970_114561936 | 4.42 |
Trim71 |
tripartite motif-containing 71 |
2916 |
0.23 |
chr15_78926966_78928482 | 4.40 |
Lgals1 |
lectin, galactose binding, soluble 1 |
998 |
0.29 |
chr9_21495923_21496771 | 4.39 |
Mir199a-1 |
microRNA 199a-1 |
217 |
0.87 |
chr15_101411658_101413570 | 4.38 |
Krt7 |
keratin 7 |
165 |
0.64 |
chr18_3509793_3510792 | 4.31 |
Bambi |
BMP and activin membrane-bound inhibitor |
2369 |
0.24 |
chr6_52202371_52204739 | 4.30 |
Hoxa5 |
homeobox A5 |
1032 |
0.2 |
chr10_5287995_5289689 | 4.29 |
Gm23573 |
predicted gene, 23573 |
68331 |
0.12 |
chr11_96318060_96319501 | 4.28 |
Hoxb4 |
homeobox B4 |
513 |
0.51 |
chr18_37720288_37722950 | 4.25 |
Pcdhgb4 |
protocadherin gamma subfamily B, 4 |
1236 |
0.14 |
chr11_87663976_87665005 | 4.22 |
Rnf43 |
ring finger protein 43 |
59 |
0.96 |
chr2_93644408_93646515 | 4.21 |
Alx4 |
aristaless-like homeobox 4 |
3073 |
0.32 |
chr17_56289386_56290549 | 4.19 |
Plin3 |
perilipin 3 |
544 |
0.6 |
chr11_83849571_83850989 | 4.19 |
Hnf1b |
HNF1 homeobox B |
217 |
0.83 |
chr11_117233043_117233605 | 4.18 |
Septin9 |
septin 9 |
1039 |
0.52 |
chr18_61663767_61665554 | 4.16 |
Carmn |
cardiac mesoderm enhancer-associated non-coding RNA |
830 |
0.45 |
chr5_24474097_24475382 | 4.13 |
Agap3 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 |
525 |
0.58 |
chr6_135362982_135365483 | 4.10 |
Emp1 |
epithelial membrane protein 1 |
1164 |
0.42 |
chr1_168426195_168428871 | 4.08 |
Pbx1 |
pre B cell leukemia homeobox 1 |
3971 |
0.3 |
chr11_61485409_61486536 | 4.08 |
Mfap4 |
microfibrillar-associated protein 4 |
456 |
0.71 |
chr19_4720446_4722033 | 4.08 |
Sptbn2 |
spectrin beta, non-erythrocytic 2 |
160 |
0.92 |
chr5_119838900_119840891 | 4.05 |
Tbx5 |
T-box 5 |
3740 |
0.21 |
chr17_84185673_84188034 | 4.03 |
Zfp36l2 |
zinc finger protein 36, C3H type-like 2 |
1094 |
0.34 |
chr18_75372210_75374418 | 4.02 |
Smad7 |
SMAD family member 7 |
1600 |
0.41 |
chr11_85888239_85889268 | 4.02 |
Tbx4 |
T-box 4 |
1310 |
0.41 |
chr6_23247289_23250418 | 3.99 |
Fezf1 |
Fez family zinc finger 1 |
491 |
0.76 |
chr5_137610176_137611504 | 3.99 |
Pcolce |
procollagen C-endopeptidase enhancer protein |
138 |
0.86 |
chr13_63273798_63275383 | 3.97 |
Gm47585 |
predicted gene, 47585 |
990 |
0.28 |
chr9_75775275_75776608 | 3.97 |
Bmp5 |
bone morphogenetic protein 5 |
577 |
0.78 |
chr11_96003142_96003707 | 3.96 |
Gm29202 |
predicted gene 29202 |
2465 |
0.13 |
chr2_167539777_167540513 | 3.93 |
Snai1 |
snail family zinc finger 1 |
1950 |
0.22 |
chr7_139020697_139021233 | 3.90 |
Gm45613 |
predicted gene 45613 |
34 |
0.98 |
chr1_135258064_135259220 | 3.85 |
Elf3 |
E74-like factor 3 |
74 |
0.95 |
chr6_126163282_126164936 | 3.85 |
Ntf3 |
neurotrophin 3 |
851 |
0.73 |
chr11_98446534_98448432 | 3.85 |
Grb7 |
growth factor receptor bound protein 7 |
415 |
0.68 |
chr15_78926025_78926879 | 3.83 |
Lgals1 |
lectin, galactose binding, soluble 1 |
273 |
0.78 |
chr6_52233543_52234485 | 3.83 |
Hoxa10 |
homeobox A10 |
690 |
0.34 |
chr9_58128949_58130350 | 3.79 |
Stra6 |
stimulated by retinoic acid gene 6 |
148 |
0.93 |
chr7_99237308_99238665 | 3.75 |
Mogat2 |
monoacylglycerol O-acyltransferase 2 |
608 |
0.62 |
chr7_101394207_101396000 | 3.75 |
Arap1 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
448 |
0.73 |
chr5_41761064_41762577 | 3.70 |
Nkx3-2 |
NK3 homeobox 2 |
2681 |
0.32 |
chr7_99594627_99596228 | 3.69 |
Arrb1 |
arrestin, beta 1 |
804 |
0.48 |
chr5_67227248_67228871 | 3.67 |
Tmem33 |
transmembrane protein 33 |
32506 |
0.14 |
chr8_92356309_92358734 | 3.66 |
Irx5 |
Iroquois homeobox 5 |
104 |
0.95 |
chr16_25802324_25803670 | 3.66 |
Trp63 |
transformation related protein 63 |
1081 |
0.63 |
chr2_84936571_84938205 | 3.65 |
Slc43a3 |
solute carrier family 43, member 3 |
498 |
0.71 |
chr8_57333046_57334560 | 3.65 |
Gm34030 |
predicted gene, 34030 |
584 |
0.59 |
chr2_57997628_57998772 | 3.64 |
Galnt5 |
polypeptide N-acetylgalactosaminyltransferase 5 |
316 |
0.9 |
chr7_142082140_142083011 | 3.61 |
Gm25416 |
predicted gene, 25416 |
4138 |
0.1 |
chr12_109454708_109455197 | 3.59 |
Dlk1 |
delta like non-canonical Notch ligand 1 |
757 |
0.48 |
chr9_75777739_75778295 | 3.53 |
Bmp5 |
bone morphogenetic protein 5 |
2653 |
0.3 |
chr3_129223881_129225649 | 3.52 |
Gm43697 |
predicted gene 43697 |
763 |
0.61 |
chr2_163396823_163398215 | 3.49 |
Jph2 |
junctophilin 2 |
430 |
0.77 |
chr8_121124848_121126422 | 3.48 |
Foxl1 |
forkhead box L1 |
2305 |
0.19 |
chr6_52164011_52165366 | 3.48 |
Hoxa2 |
homeobox A2 |
143 |
0.83 |
chr12_109455257_109457986 | 3.46 |
Dlk1 |
delta like non-canonical Notch ligand 1 |
2426 |
0.16 |
chr11_96928897_96930218 | 3.45 |
Prr15l |
proline rich 15-like |
163 |
0.89 |
chr9_108104524_108105208 | 3.43 |
Gm47303 |
predicted gene, 47303 |
1620 |
0.16 |
chr8_89036575_89038609 | 3.40 |
Sall1 |
spalt like transcription factor 1 |
6570 |
0.23 |
chr9_21015148_21016366 | 3.39 |
Icam1 |
intercellular adhesion molecule 1 |
228 |
0.81 |
chr7_141079729_141081054 | 3.38 |
Pkp3 |
plakophilin 3 |
611 |
0.5 |
chr10_93831152_93832503 | 3.38 |
Usp44 |
ubiquitin specific peptidase 44 |
272 |
0.88 |
chr5_119685576_119687800 | 3.37 |
Tbx3os2 |
T-box 3, opposite strand 2 |
4530 |
0.17 |
chr5_67097111_67099075 | 3.36 |
Phox2b |
paired-like homeobox 2b |
964 |
0.51 |
chr18_37742006_37744626 | 3.36 |
Pcdhgb6 |
protocadherin gamma subfamily B, 6 |
1222 |
0.15 |
chr2_167540595_167541629 | 3.35 |
Snai1 |
snail family zinc finger 1 |
2917 |
0.16 |
chr11_117231910_117232833 | 3.35 |
Septin9 |
septin 9 |
86 |
0.97 |
chr5_119830922_119832010 | 3.35 |
Gm43050 |
predicted gene 43050 |
325 |
0.82 |
chr2_35557994_35559313 | 3.34 |
Gm13446 |
predicted gene 13446 |
49 |
0.85 |
chr3_99248252_99249856 | 3.34 |
Tbx15 |
T-box 15 |
4706 |
0.18 |
chr6_30172641_30174725 | 3.34 |
Rncr4 |
retina expressed non-coding RNA 4 |
790 |
0.51 |
chr13_53465314_53466718 | 3.33 |
Msx2 |
msh homeobox 2 |
7058 |
0.2 |
chr7_3676625_3677631 | 3.33 |
Tmc4 |
transmembrane channel-like gene family 4 |
335 |
0.7 |
chr6_52174920_52176658 | 3.33 |
Hoxaas3 |
Hoxa cluster antisense RNA 3 |
554 |
0.41 |
chr7_75612178_75613652 | 3.31 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
631 |
0.75 |
chr16_17799009_17799325 | 3.30 |
Scarf2 |
scavenger receptor class F, member 2 |
1817 |
0.19 |
chr13_56159603_56160215 | 3.30 |
Gm25148 |
predicted gene, 25148 |
7691 |
0.15 |
chr17_29415978_29416957 | 3.30 |
Gm36199 |
predicted gene, 36199 |
16368 |
0.11 |
chr3_95172192_95174377 | 3.29 |
Sema6c |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C |
2479 |
0.12 |
chr9_119052293_119053778 | 3.29 |
Vill |
villin-like |
170 |
0.93 |
chr10_103027884_103029519 | 3.28 |
Alx1 |
ALX homeobox 1 |
74 |
0.97 |
chr17_85684987_85686256 | 3.28 |
Six2 |
sine oculis-related homeobox 2 |
2633 |
0.25 |
chrX_52612336_52613992 | 3.27 |
Gpc3 |
glypican 3 |
757 |
0.67 |
chr10_22818712_22820254 | 3.27 |
Tcf21 |
transcription factor 21 |
676 |
0.65 |
chr2_35623294_35623923 | 3.27 |
Dab2ip |
disabled 2 interacting protein |
1448 |
0.46 |
chr15_27783095_27784730 | 3.25 |
Trio |
triple functional domain (PTPRF interacting) |
4726 |
0.26 |
chrX_96456094_96457321 | 3.23 |
Heph |
hephaestin |
279 |
0.62 |
chr5_119673183_119673803 | 3.23 |
Tbx3 |
T-box 3 |
1952 |
0.23 |
chr3_84269309_84270900 | 3.23 |
Trim2 |
tripartite motif-containing 2 |
687 |
0.77 |
chr19_60225145_60226660 | 3.22 |
4933412A08Rik |
RIKEN cDNA 4933412A08 gene |
432 |
0.65 |
chr18_38281065_38284356 | 3.22 |
Pcdh12 |
protocadherin 12 |
1647 |
0.2 |
chr11_104318691_104319872 | 3.21 |
Mapt |
microtubule-associated protein tau |
1248 |
0.44 |
chr5_125386055_125387945 | 3.20 |
Ubc |
ubiquitin C |
2186 |
0.18 |
chr9_123480120_123480887 | 3.20 |
Limd1 |
LIM domains containing 1 |
107 |
0.97 |
chr8_121080367_121081368 | 3.19 |
Fendrr |
Foxf1 adjacent non-coding developmental regulatory RNA |
2165 |
0.19 |
chrX_164373324_164374363 | 3.19 |
Vegfd |
vascular endothelial growth factor D |
465 |
0.82 |
chr6_124717857_124719000 | 3.19 |
Mir200c |
microRNA 200c |
38 |
0.7 |
chr6_52259871_52261414 | 3.18 |
Hoxa13 |
homeobox A13 |
160 |
0.84 |
chr14_55712926_55713937 | 3.17 |
Tgm1 |
transglutaminase 1, K polypeptide |
61 |
0.91 |
chr1_74090075_74091356 | 3.16 |
Tns1 |
tensin 1 |
636 |
0.71 |
chr8_57319308_57320679 | 3.16 |
Hand2os1 |
Hand2, opposite strand 1 |
63 |
0.94 |
chr6_124719018_124719688 | 3.16 |
Gm15884 |
predicted gene 15884 |
522 |
0.36 |
chr12_73044500_73046647 | 3.16 |
Six1 |
sine oculis-related homeobox 1 |
282 |
0.92 |
chrX_143825863_143827628 | 3.15 |
Capn6 |
calpain 6 |
587 |
0.46 |
chrX_53053916_53055220 | 3.13 |
Mir322 |
microRNA 322 |
219 |
0.66 |
chr11_117779316_117780928 | 3.12 |
Tmc6 |
transmembrane channel-like gene family 6 |
472 |
0.61 |
chr8_108699179_108700683 | 3.12 |
Zfhx3 |
zinc finger homeobox 3 |
3169 |
0.32 |
chr11_102145120_102148094 | 3.12 |
Nags |
N-acetylglutamate synthase |
241 |
0.58 |
chr4_126150157_126151254 | 3.12 |
Eva1b |
eva-1 homolog B (C. elegans) |
2173 |
0.18 |
chr19_25381686_25382798 | 3.10 |
Kank1 |
KN motif and ankyrin repeat domains 1 |
13061 |
0.21 |
chr10_34483356_34484742 | 3.08 |
Frk |
fyn-related kinase |
517 |
0.83 |
chr9_55543267_55546069 | 3.08 |
Isl2 |
insulin related protein 2 (islet 2) |
2332 |
0.22 |
chr10_86700286_86701944 | 3.08 |
Hsp90b1 |
heat shock protein 90, beta (Grp94), member 1 |
853 |
0.34 |
chr15_89322584_89323784 | 3.08 |
Adm2 |
adrenomedullin 2 |
464 |
0.63 |
chr4_106804374_106805428 | 3.08 |
Acot11 |
acyl-CoA thioesterase 11 |
97 |
0.96 |
chr6_136660962_136662291 | 3.07 |
Plbd1 |
phospholipase B domain containing 1 |
247 |
0.91 |
chr3_153908033_153909893 | 3.06 |
Snord45b |
small nucleolar RNA, C/D box 45B |
1670 |
0.17 |
chr16_45093540_45095213 | 3.04 |
Ccdc80 |
coiled-coil domain containing 80 |
323 |
0.91 |
chr5_74197172_74198949 | 3.04 |
Rasl11b |
RAS-like, family 11, member B |
169 |
0.94 |
chr12_86891509_86893562 | 3.03 |
Irf2bpl |
interferon regulatory factor 2 binding protein-like |
7737 |
0.19 |
chr6_127251095_127252240 | 3.03 |
Gm43635 |
predicted gene 43635 |
2977 |
0.18 |
chr5_31251110_31252754 | 3.03 |
Krtcap3 |
keratinocyte associated protein 3 |
5 |
0.93 |
chr3_131271069_131271533 | 3.03 |
Hadh |
hydroxyacyl-Coenzyme A dehydrogenase |
723 |
0.62 |
chr8_27086331_27087092 | 3.02 |
Adgra2 |
adhesion G protein-coupled receptor A2 |
1113 |
0.36 |
chr14_46389448_46390599 | 3.01 |
Bmp4 |
bone morphogenetic protein 4 |
512 |
0.7 |
chr11_120948479_120950230 | 3.01 |
Slc16a3 |
solute carrier family 16 (monocarboxylic acid transporters), member 3 |
273 |
0.84 |
chr10_111335849_111336733 | 3.01 |
Gm40761 |
predicted gene, 40761 |
833 |
0.64 |
chr16_5007275_5008433 | 3.01 |
Smim22 |
small integral membrane protein 22 |
86 |
0.85 |
chr18_35739288_35740804 | 2.99 |
Sting1 |
stimulator of interferon response cGAMP interactor 1 |
30 |
0.95 |
chr9_41326803_41329121 | 2.99 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
676 |
0.69 |
chr5_113797844_113798192 | 2.98 |
Tmem119 |
transmembrane protein 119 |
2428 |
0.16 |
chr3_129202581_129205165 | 2.97 |
Pitx2 |
paired-like homeodomain transcription factor 2 |
74 |
0.97 |
chr15_102955712_102957246 | 2.97 |
Hoxc11 |
homeobox C11 |
2052 |
0.15 |
chr4_136172411_136173624 | 2.97 |
E2f2 |
E2F transcription factor 2 |
623 |
0.65 |
chr17_25819041_25820447 | 2.96 |
Fbxl16 |
F-box and leucine-rich repeat protein 16 |
1685 |
0.11 |
chr16_23110812_23112317 | 2.96 |
Gm24616 |
predicted gene, 24616 |
53 |
0.67 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.4 | 25.2 | GO:0010159 | specification of organ position(GO:0010159) |
5.4 | 16.2 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
5.2 | 10.5 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
5.0 | 15.0 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
4.9 | 14.6 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
4.3 | 12.9 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
4.3 | 21.4 | GO:0007494 | midgut development(GO:0007494) |
4.1 | 12.2 | GO:0003166 | bundle of His development(GO:0003166) |
4.0 | 12.0 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
3.6 | 7.3 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
3.5 | 10.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
3.4 | 10.1 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
3.3 | 6.6 | GO:0070384 | Harderian gland development(GO:0070384) |
3.2 | 9.6 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
3.0 | 9.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
3.0 | 9.0 | GO:0072125 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
3.0 | 3.0 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
3.0 | 8.9 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
2.8 | 22.6 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
2.8 | 11.2 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
2.8 | 5.5 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
2.7 | 2.7 | GO:0060435 | bronchiole development(GO:0060435) |
2.7 | 5.3 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
2.7 | 5.3 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
2.6 | 7.9 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
2.6 | 10.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
2.6 | 7.7 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
2.5 | 4.9 | GO:0060594 | mammary gland specification(GO:0060594) |
2.5 | 4.9 | GO:0007403 | glial cell fate determination(GO:0007403) |
2.4 | 4.8 | GO:0018992 | germ-line sex determination(GO:0018992) |
2.3 | 6.9 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
2.2 | 6.7 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
2.2 | 6.7 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
2.2 | 2.2 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
2.2 | 6.5 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
2.2 | 6.5 | GO:0002930 | trabecular meshwork development(GO:0002930) |
2.1 | 6.4 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
2.0 | 6.1 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
2.0 | 4.0 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
1.9 | 5.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.9 | 9.5 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
1.9 | 5.7 | GO:0007418 | ventral midline development(GO:0007418) |
1.9 | 1.9 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
1.9 | 3.8 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.8 | 7.4 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
1.8 | 5.5 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
1.8 | 1.8 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
1.7 | 12.2 | GO:0071493 | cellular response to UV-B(GO:0071493) |
1.7 | 6.9 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.7 | 5.2 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
1.7 | 5.1 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
1.7 | 1.7 | GO:0003264 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) |
1.7 | 1.7 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
1.6 | 4.9 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
1.6 | 4.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.6 | 8.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
1.6 | 4.7 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.5 | 7.7 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
1.5 | 15.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
1.5 | 1.5 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
1.5 | 7.7 | GO:0060379 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) cardiac muscle cell myoblast differentiation(GO:0060379) |
1.5 | 4.6 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
1.5 | 7.6 | GO:0030578 | PML body organization(GO:0030578) |
1.5 | 4.5 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.5 | 9.0 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.5 | 4.5 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
1.5 | 1.5 | GO:2000064 | regulation of cortisol biosynthetic process(GO:2000064) |
1.5 | 1.5 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
1.5 | 7.3 | GO:0071476 | cellular hypotonic response(GO:0071476) |
1.5 | 2.9 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.4 | 5.8 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
1.4 | 10.1 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
1.4 | 2.9 | GO:0048320 | axial mesoderm formation(GO:0048320) |
1.4 | 5.7 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
1.4 | 4.3 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
1.4 | 1.4 | GO:0048382 | mesendoderm development(GO:0048382) |
1.4 | 4.2 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.4 | 4.2 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.4 | 4.2 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.4 | 4.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.4 | 5.6 | GO:0021569 | rhombomere 3 development(GO:0021569) |
1.4 | 4.1 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
1.4 | 2.8 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.4 | 5.5 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
1.4 | 5.5 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.4 | 8.1 | GO:0048539 | bone marrow development(GO:0048539) |
1.3 | 1.3 | GO:0061055 | myotome development(GO:0061055) |
1.3 | 1.3 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
1.3 | 6.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.3 | 4.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
1.3 | 27.4 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
1.3 | 1.3 | GO:0043587 | tongue morphogenesis(GO:0043587) |
1.3 | 1.3 | GO:1901256 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
1.3 | 2.6 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.3 | 3.8 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.3 | 3.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.3 | 7.6 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
1.3 | 3.8 | GO:0048557 | embryonic digestive tract morphogenesis(GO:0048557) |
1.3 | 3.8 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
1.2 | 3.6 | GO:0014029 | neural crest formation(GO:0014029) |
1.2 | 1.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.2 | 7.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.2 | 10.7 | GO:0060056 | mammary gland involution(GO:0060056) |
1.2 | 1.2 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
1.2 | 2.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.2 | 2.3 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.2 | 2.3 | GO:0065001 | specification of axis polarity(GO:0065001) |
1.2 | 10.5 | GO:0048368 | lateral mesoderm development(GO:0048368) |
1.2 | 2.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
1.2 | 5.8 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.1 | 11.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
1.1 | 1.1 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
1.1 | 3.4 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.1 | 2.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.1 | 3.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.1 | 4.5 | GO:0060591 | chondroblast differentiation(GO:0060591) |
1.1 | 1.1 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
1.1 | 2.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.1 | 1.1 | GO:0061183 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
1.1 | 3.3 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
1.1 | 5.5 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
1.1 | 4.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.1 | 3.3 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.1 | 4.4 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
1.1 | 2.2 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.1 | 1.1 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
1.1 | 3.2 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.1 | 4.3 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
1.1 | 3.2 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
1.1 | 4.3 | GO:0046618 | drug export(GO:0046618) |
1.1 | 1.1 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
1.1 | 7.4 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
1.1 | 3.2 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
1.1 | 6.3 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
1.1 | 1.1 | GO:1901382 | Spemann organizer formation(GO:0060061) chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
1.0 | 1.0 | GO:0001757 | somite specification(GO:0001757) |
1.0 | 7.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
1.0 | 2.1 | GO:0048880 | sensory system development(GO:0048880) |
1.0 | 5.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
1.0 | 1.0 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.0 | 4.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.0 | 3.1 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
1.0 | 4.1 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
1.0 | 10.3 | GO:0010226 | response to lithium ion(GO:0010226) |
1.0 | 5.1 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
1.0 | 5.1 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
1.0 | 3.1 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
1.0 | 7.1 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
1.0 | 12.1 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
1.0 | 3.0 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
1.0 | 6.0 | GO:0051639 | actin filament network formation(GO:0051639) |
1.0 | 3.0 | GO:0000087 | mitotic M phase(GO:0000087) |
1.0 | 2.0 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
1.0 | 2.0 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
1.0 | 2.0 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
1.0 | 1.9 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
1.0 | 1.9 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
1.0 | 1.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.0 | 1.9 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.9 | 3.8 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.9 | 1.9 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.9 | 0.9 | GO:0014010 | regulation of Schwann cell proliferation(GO:0010624) Schwann cell proliferation(GO:0014010) |
0.9 | 2.8 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.9 | 1.9 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.9 | 2.8 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.9 | 4.6 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.9 | 2.8 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.9 | 4.6 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.9 | 2.7 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.9 | 1.8 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.9 | 3.6 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.9 | 1.8 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.9 | 1.8 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.9 | 2.7 | GO:0060005 | vestibular reflex(GO:0060005) |
0.9 | 2.7 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.9 | 0.9 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.9 | 0.9 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.9 | 3.5 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.9 | 0.9 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.9 | 2.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.9 | 4.4 | GO:0070627 | ferrous iron import(GO:0070627) |
0.9 | 1.7 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.9 | 1.7 | GO:1901166 | neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
0.9 | 3.5 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.9 | 2.6 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.9 | 1.7 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.9 | 2.6 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.9 | 0.9 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.9 | 2.6 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.8 | 0.8 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.8 | 4.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.8 | 1.7 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.8 | 1.7 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.8 | 3.3 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.8 | 1.7 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.8 | 2.5 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.8 | 0.8 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.8 | 0.8 | GO:0090579 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.8 | 1.6 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.8 | 6.4 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.8 | 2.4 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.8 | 2.4 | GO:0033504 | floor plate development(GO:0033504) |
0.8 | 3.2 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.8 | 0.8 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.8 | 4.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.8 | 4.8 | GO:0006477 | protein sulfation(GO:0006477) |
0.8 | 0.8 | GO:0061010 | gall bladder development(GO:0061010) |
0.8 | 1.6 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.8 | 2.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.8 | 3.2 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.8 | 5.5 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.8 | 2.4 | GO:0002159 | desmosome assembly(GO:0002159) |
0.8 | 2.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.8 | 4.7 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.8 | 0.8 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.8 | 7.8 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.8 | 3.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.8 | 3.9 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.8 | 3.1 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.8 | 5.4 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.8 | 1.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.8 | 3.8 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.8 | 3.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.8 | 1.5 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.8 | 2.3 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.8 | 1.5 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.8 | 3.8 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.8 | 3.0 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.8 | 0.8 | GO:0060290 | transdifferentiation(GO:0060290) |
0.8 | 2.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.8 | 1.5 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.7 | 0.7 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.7 | 13.4 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.7 | 0.7 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.7 | 0.7 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.7 | 2.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.7 | 0.7 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.7 | 3.7 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.7 | 2.2 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.7 | 2.2 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.7 | 2.9 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.7 | 5.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.7 | 1.5 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.7 | 4.4 | GO:0071295 | cellular response to vitamin(GO:0071295) |
0.7 | 5.8 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.7 | 3.6 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.7 | 9.4 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.7 | 2.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.7 | 2.2 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.7 | 8.6 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.7 | 6.5 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.7 | 0.7 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.7 | 10.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.7 | 1.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.7 | 3.6 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.7 | 2.9 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.7 | 2.1 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.7 | 0.7 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.7 | 0.7 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.7 | 2.8 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.7 | 1.4 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.7 | 2.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.7 | 2.1 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.7 | 2.8 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.7 | 4.2 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.7 | 4.2 | GO:0015671 | oxygen transport(GO:0015671) |
0.7 | 1.4 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.7 | 1.4 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.7 | 7.0 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.7 | 1.4 | GO:0019401 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
0.7 | 2.1 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.7 | 0.7 | GO:0003032 | detection of oxygen(GO:0003032) |
0.7 | 3.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.7 | 2.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.7 | 0.7 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.7 | 2.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.7 | 13.7 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.7 | 4.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.7 | 2.0 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.7 | 3.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.7 | 2.7 | GO:0070836 | caveola assembly(GO:0070836) |
0.7 | 2.7 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.7 | 1.3 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.7 | 0.7 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.7 | 6.0 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
0.7 | 1.3 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.7 | 0.7 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.7 | 32.4 | GO:0035113 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
0.7 | 2.0 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.7 | 2.0 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.7 | 1.3 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.7 | 5.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.7 | 0.7 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.6 | 1.9 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.6 | 1.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.6 | 3.2 | GO:0060068 | female genitalia development(GO:0030540) vagina development(GO:0060068) |
0.6 | 4.5 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.6 | 1.3 | GO:0032439 | endosome localization(GO:0032439) |
0.6 | 3.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.6 | 1.9 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.6 | 1.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.6 | 5.8 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.6 | 0.6 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.6 | 0.6 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.6 | 5.7 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.6 | 3.8 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.6 | 2.5 | GO:0019532 | oxalate transport(GO:0019532) |
0.6 | 1.3 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.6 | 1.3 | GO:0032252 | secretory granule localization(GO:0032252) |
0.6 | 4.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.6 | 1.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.6 | 5.0 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.6 | 3.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.6 | 1.9 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.6 | 4.4 | GO:0015669 | gas transport(GO:0015669) |
0.6 | 1.2 | GO:1903798 | regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) |
0.6 | 0.6 | GO:1904888 | cranial skeletal system development(GO:1904888) |
0.6 | 2.5 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.6 | 0.6 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.6 | 1.8 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.6 | 3.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.6 | 1.2 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.6 | 3.6 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.6 | 0.6 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.6 | 1.8 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.6 | 4.8 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.6 | 1.2 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.6 | 5.9 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.6 | 1.8 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.6 | 1.2 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.6 | 1.8 | GO:0036035 | osteoclast development(GO:0036035) |
0.6 | 3.5 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.6 | 0.6 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.6 | 1.8 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.6 | 2.3 | GO:0031033 | myosin filament organization(GO:0031033) |
0.6 | 4.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.6 | 2.9 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.6 | 1.8 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.6 | 1.8 | GO:0035878 | nail development(GO:0035878) |
0.6 | 2.3 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.6 | 2.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.6 | 6.3 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.6 | 1.7 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.6 | 26.7 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.6 | 0.6 | GO:0035739 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) |
0.6 | 1.1 | GO:0070268 | cornification(GO:0070268) |
0.6 | 4.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.6 | 2.3 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.6 | 1.1 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
0.6 | 1.7 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.6 | 3.4 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.6 | 1.1 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
0.6 | 1.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.6 | 1.7 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.6 | 4.5 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.6 | 3.4 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.6 | 0.6 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.6 | 1.1 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.6 | 1.7 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.6 | 2.8 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.6 | 1.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.6 | 0.6 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.5 | 0.5 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.5 | 1.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.5 | 1.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.5 | 6.0 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.5 | 1.6 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.5 | 0.5 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.5 | 0.5 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.5 | 1.1 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.5 | 1.1 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.5 | 1.1 | GO:0050904 | diapedesis(GO:0050904) |
0.5 | 1.1 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
0.5 | 0.5 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.5 | 2.1 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.5 | 1.6 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.5 | 1.1 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.5 | 5.3 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.5 | 1.0 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.5 | 1.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.5 | 0.5 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.5 | 1.6 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.5 | 0.5 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.5 | 0.5 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.5 | 1.6 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.5 | 0.5 | GO:0055093 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.5 | 0.5 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.5 | 2.6 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.5 | 2.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.5 | 1.5 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.5 | 0.5 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.5 | 1.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.5 | 1.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.5 | 1.0 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.5 | 4.6 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.5 | 1.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.5 | 2.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.5 | 1.0 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.5 | 1.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.5 | 2.0 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.5 | 0.5 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.5 | 2.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.5 | 1.5 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.5 | 2.0 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.5 | 1.5 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.5 | 2.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.5 | 14.9 | GO:0060021 | palate development(GO:0060021) |
0.5 | 1.5 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.5 | 1.0 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.5 | 0.5 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.5 | 1.5 | GO:0015705 | iodide transport(GO:0015705) |
0.5 | 2.0 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.5 | 1.0 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.5 | 0.5 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.5 | 0.5 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.5 | 0.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.5 | 3.4 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.5 | 3.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.5 | 1.0 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.5 | 1.5 | GO:0060264 | respiratory burst involved in inflammatory response(GO:0002536) regulation of respiratory burst involved in inflammatory response(GO:0060264) |
0.5 | 0.5 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.5 | 1.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.5 | 6.3 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.5 | 1.0 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.5 | 1.5 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.5 | 1.4 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.5 | 0.5 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.5 | 1.4 | GO:0001781 | neutrophil apoptotic process(GO:0001781) |
0.5 | 1.0 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.5 | 0.5 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.5 | 2.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.5 | 5.7 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.5 | 5.2 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.5 | 3.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.5 | 9.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.5 | 1.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.5 | 7.9 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.5 | 1.8 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.5 | 6.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.5 | 0.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.5 | 0.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.5 | 1.4 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.5 | 2.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.5 | 2.3 | GO:0018158 | protein oxidation(GO:0018158) |
0.4 | 0.9 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.4 | 0.9 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.4 | 1.8 | GO:0044351 | macropinocytosis(GO:0044351) |
0.4 | 1.8 | GO:0051451 | myoblast migration(GO:0051451) |
0.4 | 2.7 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.4 | 1.8 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.4 | 1.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.4 | 1.8 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.4 | 1.3 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.4 | 2.7 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.4 | 0.9 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.4 | 0.9 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.4 | 2.2 | GO:0018101 | protein citrullination(GO:0018101) |
0.4 | 8.4 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.4 | 2.2 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.4 | 2.6 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.4 | 3.1 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.4 | 1.7 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.4 | 0.9 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.4 | 2.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.4 | 0.4 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.4 | 1.3 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.4 | 3.4 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.4 | 0.4 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) positive regulation of deoxyribonuclease activity(GO:0032077) |
0.4 | 0.4 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.4 | 0.4 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.4 | 5.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.4 | 0.4 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.4 | 1.7 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.4 | 0.4 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.4 | 1.3 | GO:1903232 | melanosome assembly(GO:1903232) |
0.4 | 0.8 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.4 | 0.8 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.4 | 0.8 | GO:0006907 | pinocytosis(GO:0006907) |
0.4 | 1.7 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.4 | 0.8 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.4 | 0.8 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.4 | 9.4 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.4 | 1.2 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.4 | 1.6 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.4 | 0.4 | GO:0001796 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.4 | 0.8 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.4 | 1.2 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.4 | 0.8 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.4 | 0.4 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.4 | 2.4 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.4 | 1.2 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.4 | 2.0 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.4 | 4.8 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.4 | 0.8 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.4 | 0.8 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.4 | 0.8 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.4 | 1.6 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.4 | 7.6 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.4 | 0.8 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.4 | 2.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.4 | 2.8 | GO:0051026 | chiasma assembly(GO:0051026) |
0.4 | 3.9 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.4 | 0.4 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.4 | 1.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.4 | 1.6 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.4 | 0.4 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.4 | 1.6 | GO:0060964 | regulation of gene silencing by miRNA(GO:0060964) |
0.4 | 0.8 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.4 | 0.4 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.4 | 0.4 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.4 | 1.2 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.4 | 0.8 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.4 | 8.5 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.4 | 1.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.4 | 0.8 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.4 | 1.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 0.4 | GO:0035932 | renin-angiotensin regulation of aldosterone production(GO:0002018) mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.4 | 1.5 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.4 | 1.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.4 | 1.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.4 | 2.7 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.4 | 4.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.4 | 0.8 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.4 | 1.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.4 | 5.7 | GO:0050892 | intestinal absorption(GO:0050892) |
0.4 | 0.8 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.4 | 1.9 | GO:0002076 | osteoblast development(GO:0002076) |
0.4 | 3.4 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.4 | 0.4 | GO:0009750 | response to fructose(GO:0009750) |
0.4 | 0.4 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.4 | 1.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.4 | 0.4 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.4 | 0.7 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.4 | 0.4 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.4 | 1.1 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.4 | 0.7 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.4 | 1.1 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.4 | 1.5 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.4 | 3.0 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.4 | 1.8 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.4 | 1.5 | GO:0035108 | appendage morphogenesis(GO:0035107) limb morphogenesis(GO:0035108) |
0.4 | 1.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.4 | 2.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.4 | 1.8 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.4 | 1.5 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.4 | 0.4 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.4 | 0.7 | GO:0016264 | gap junction assembly(GO:0016264) |
0.4 | 3.6 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.4 | 0.4 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.4 | 3.6 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.4 | 1.8 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.4 | 0.4 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.4 | 2.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.4 | 0.4 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.4 | 1.8 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.4 | 2.1 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.4 | 0.7 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.4 | 1.4 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.4 | 0.4 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.4 | 3.2 | GO:0001945 | lymph vessel development(GO:0001945) |
0.4 | 1.1 | GO:0042637 | catagen(GO:0042637) |
0.4 | 1.8 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.4 | 1.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.4 | 0.7 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.3 | 1.4 | GO:0051031 | tRNA transport(GO:0051031) |
0.3 | 0.7 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.3 | 2.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 2.8 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.3 | 3.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.3 | 0.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.3 | 0.7 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 3.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.3 | 0.7 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.3 | 0.3 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.3 | 0.7 | GO:0019661 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.3 | 2.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.3 | 0.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.3 | 1.7 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.3 | 0.7 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.3 | 0.3 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.3 | 0.7 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.3 | 1.0 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.3 | 1.0 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.3 | 1.0 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.3 | 1.4 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.3 | 1.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.3 | 0.7 | GO:0072757 | cellular response to camptothecin(GO:0072757) |
0.3 | 0.3 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.3 | 1.4 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.3 | 2.0 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.3 | 1.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.3 | 5.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.3 | 1.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.3 | 1.7 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.3 | 1.7 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.3 | 0.7 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.3 | 4.7 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.3 | 1.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.3 | 1.0 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.3 | 2.7 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.3 | 3.3 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.3 | 1.7 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.3 | 0.7 | GO:0048263 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.3 | 2.7 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.3 | 1.3 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.3 | 1.0 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.3 | 0.3 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.3 | 1.3 | GO:0015858 | nucleoside transport(GO:0015858) |
0.3 | 0.7 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.3 | 1.3 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.3 | 1.0 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.3 | 1.0 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.3 | 1.0 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.3 | 1.3 | GO:0060430 | lung saccule development(GO:0060430) |
0.3 | 0.6 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.3 | 0.3 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.3 | 1.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.3 | 0.3 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.3 | 3.5 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.3 | 0.6 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.3 | 1.0 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.3 | 0.9 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.3 | 0.3 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.3 | 5.0 | GO:0060349 | bone morphogenesis(GO:0060349) |
0.3 | 2.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 0.3 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.3 | 0.6 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.3 | 0.6 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.3 | 5.6 | GO:0043297 | apical junction assembly(GO:0043297) |
0.3 | 2.5 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.3 | 0.9 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.3 | 0.9 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.3 | 0.9 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.3 | 1.8 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.3 | 0.9 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.3 | 1.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.3 | 1.8 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.3 | 0.6 | GO:0086029 | Purkinje myocyte action potential(GO:0086017) Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.3 | 0.3 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.3 | 0.3 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.3 | 0.6 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.3 | 1.5 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.3 | 1.8 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.3 | 2.4 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.3 | 0.3 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.3 | 1.8 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.3 | 0.9 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.3 | 0.9 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.3 | 3.0 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.3 | 1.5 | GO:0072395 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.3 | 0.6 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 0.6 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.3 | 1.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.3 | 3.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 2.7 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.3 | 0.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 1.8 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.3 | 2.1 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.3 | 3.2 | GO:0042730 | fibrinolysis(GO:0042730) |
0.3 | 0.3 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.3 | 0.3 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.3 | 0.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 0.3 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.3 | 0.3 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.3 | 0.6 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.3 | 2.0 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.3 | 0.6 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.3 | 5.5 | GO:0014823 | response to activity(GO:0014823) |
0.3 | 1.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 0.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.3 | 0.9 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.3 | 0.3 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.3 | 0.6 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.3 | 0.6 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.3 | 2.9 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.3 | 2.0 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.3 | 0.6 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.3 | 0.6 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.3 | 0.3 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.3 | 1.1 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.3 | 0.8 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.3 | 0.8 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.3 | 0.8 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.3 | 7.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.3 | 0.8 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.3 | 3.7 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.3 | 0.8 | GO:0061042 | vascular wound healing(GO:0061042) |
0.3 | 0.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.3 | 0.3 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.3 | 1.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.3 | 0.3 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.3 | 1.1 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
0.3 | 0.3 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.3 | 1.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.3 | 0.6 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.3 | 1.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.3 | 4.4 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.3 | 0.3 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.3 | 1.6 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.3 | 3.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 1.1 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) |
0.3 | 0.3 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.3 | 0.8 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.3 | 2.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.3 | 1.3 | GO:0051775 | response to redox state(GO:0051775) |
0.3 | 1.3 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.3 | 3.2 | GO:0034340 | response to type I interferon(GO:0034340) |
0.3 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.3 | 0.5 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.3 | 0.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.3 | 0.8 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.3 | 1.9 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.3 | 0.5 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
0.3 | 2.9 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.3 | 0.8 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.3 | 0.3 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.3 | 1.0 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.3 | 3.7 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.3 | 0.3 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.3 | 0.3 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.3 | 0.8 | GO:0002369 | T cell cytokine production(GO:0002369) CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
0.3 | 0.8 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.3 | 0.5 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.3 | 1.0 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.3 | 0.5 | GO:0008050 | female courtship behavior(GO:0008050) |
0.3 | 3.1 | GO:0045214 | sarcomere organization(GO:0045214) |
0.3 | 0.8 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) |
0.3 | 0.8 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.3 | 0.5 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.3 | 2.3 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.3 | 2.3 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.3 | 0.8 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.3 | 0.5 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.3 | 0.3 | GO:0035564 | regulation of kidney size(GO:0035564) |
0.3 | 0.8 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.3 | 0.3 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.3 | 1.5 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.3 | 0.3 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.3 | 1.5 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.3 | 0.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.2 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.2 | 0.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 3.5 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.2 | 0.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 0.2 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 1.2 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.2 | 2.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 1.0 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 1.5 | GO:0034204 | lipid translocation(GO:0034204) |
0.2 | 0.2 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 0.5 | GO:0072224 | metanephric glomerulus development(GO:0072224) |
0.2 | 0.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 2.4 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.2 | 0.5 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.2 | 0.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 1.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.5 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.2 | 0.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.2 | 0.5 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.2 | 0.2 | GO:0051593 | response to folic acid(GO:0051593) |
0.2 | 0.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.2 | 0.5 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 0.5 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
0.2 | 0.5 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 1.9 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.2 | 0.7 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
0.2 | 0.2 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.2 | 0.2 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.2 | 0.2 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.2 | 0.5 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.2 | 0.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.2 | 1.2 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 0.2 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.2 | 0.2 | GO:0061511 | centriole elongation(GO:0061511) |
0.2 | 0.5 | GO:0009299 | mRNA transcription(GO:0009299) |
0.2 | 0.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 0.7 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 0.7 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 0.5 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 0.7 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 0.5 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.2 | 0.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 0.7 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.2 | 0.5 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 0.5 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.2 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 4.3 | GO:0048705 | skeletal system morphogenesis(GO:0048705) |
0.2 | 0.4 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.2 | 0.7 | GO:0018214 | protein carboxylation(GO:0018214) |
0.2 | 0.9 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 1.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.2 | 1.1 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.2 | 2.0 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 1.3 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 1.1 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.2 | 0.7 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 0.4 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.2 | 0.2 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.2 | 0.7 | GO:0019081 | viral translation(GO:0019081) |
0.2 | 2.0 | GO:0070269 | pyroptosis(GO:0070269) |
0.2 | 0.9 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 0.9 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.2 | 0.4 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.2 | 0.7 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.2 | 3.0 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.2 | 0.2 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.2 | 1.1 | GO:2000351 | regulation of endothelial cell apoptotic process(GO:2000351) |
0.2 | 2.2 | GO:0000303 | response to superoxide(GO:0000303) |
0.2 | 1.5 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.2 | 0.9 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.2 | 0.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 1.5 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.2 | 0.8 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.2 | 0.8 | GO:0007379 | segment specification(GO:0007379) |
0.2 | 0.8 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.2 | 0.4 | GO:0042033 | chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) |
0.2 | 0.2 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.2 | 0.2 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.2 | 0.8 | GO:1904707 | regulation of vascular smooth muscle cell proliferation(GO:1904705) positive regulation of vascular smooth muscle cell proliferation(GO:1904707) vascular smooth muscle cell proliferation(GO:1990874) |
0.2 | 0.6 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 0.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.2 | 0.2 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.2 | 0.2 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 0.8 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 0.4 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.2 | 0.4 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.2 | 0.2 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.2 | 1.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 0.6 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 0.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.2 | 1.0 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.2 | 0.2 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.2 | 0.2 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.2 | 1.2 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
0.2 | 0.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.2 | 0.6 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 1.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.2 | 0.2 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.2 | 4.6 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.2 | 0.4 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 1.4 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 1.4 | GO:0033627 | cell adhesion mediated by integrin(GO:0033627) |
0.2 | 0.2 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.2 | 1.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 2.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 2.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 0.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.2 | 0.2 | GO:0032776 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
0.2 | 0.6 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 0.8 | GO:0032196 | transposition(GO:0032196) |
0.2 | 1.4 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.2 | 2.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 3.1 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.2 | 0.2 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.2 | 4.3 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.2 | 0.2 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.2 | 0.2 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.2 | 0.4 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 1.6 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.2 | 0.4 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.2 | 0.4 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.2 | 0.4 | GO:0046112 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) nucleobase biosynthetic process(GO:0046112) |
0.2 | 0.6 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.2 | 0.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.9 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.2 | 0.6 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 0.2 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.2 | 0.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 0.4 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.2 | 0.4 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.2 | 0.4 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 1.1 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.6 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 1.5 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.2 | 0.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 3.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 0.2 | GO:0071724 | response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.2 | 0.2 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 0.7 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.2 | 0.4 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 0.5 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.2 | 2.3 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.2 | 0.5 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.2 | 0.5 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.2 | 0.4 | GO:1901988 | negative regulation of cell cycle phase transition(GO:1901988) |
0.2 | 1.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.7 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.2 | 0.5 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 0.9 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.2 | 0.5 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 0.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 1.1 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.2 | 2.5 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.2 | 0.4 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 3.9 | GO:0031424 | keratinization(GO:0031424) |
0.2 | 0.7 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.2 | 1.0 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 1.6 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 1.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 1.0 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.2 | 1.0 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.2 | 1.5 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.2 | 0.9 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.2 | 0.3 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.2 | 1.4 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.2 | 0.2 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.2 | 2.5 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.2 | 0.5 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 1.4 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 0.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 0.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.2 | 0.2 | GO:0051132 | NK T cell activation(GO:0051132) |
0.2 | 0.3 | GO:0070266 | necroptotic process(GO:0070266) |
0.2 | 0.5 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 0.5 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 0.3 | GO:1901838 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.2 | 1.3 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.2 | 0.5 | GO:1990774 | regulation of tumor necrosis factor secretion(GO:1904467) positive regulation of tumor necrosis factor secretion(GO:1904469) tumor necrosis factor secretion(GO:1990774) |
0.2 | 0.3 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.2 | 0.2 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.2 | 2.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.2 | 1.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 2.0 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 0.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.2 | 1.0 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.2 | 0.7 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.2 | 0.8 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.2 | 0.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 0.6 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.2 | 0.3 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.2 | 0.5 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.2 | 0.3 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 1.4 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 0.2 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.2 | 0.2 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.2 | 0.3 | GO:0044838 | cell quiescence(GO:0044838) |
0.2 | 0.2 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) high-density lipoprotein particle clearance(GO:0034384) |
0.2 | 0.8 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.2 | 0.3 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.2 | 0.5 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.2 | 0.8 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.2 | 0.2 | GO:0070293 | renal absorption(GO:0070293) |
0.2 | 0.8 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.2 | 3.9 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 0.2 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.2 | 0.2 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.2 | 0.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 0.5 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.2 | 0.2 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.2 | 1.5 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.2 | 2.7 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 1.4 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.2 | 0.2 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 1.0 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 1.3 | GO:0018904 | ether metabolic process(GO:0018904) |
0.1 | 0.1 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.1 | 0.3 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.1 | 0.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 1.6 | GO:1903429 | regulation of cell maturation(GO:1903429) |
0.1 | 1.8 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.1 | 0.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.4 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.1 | 1.7 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.6 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.1 | 0.1 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.1 | 0.3 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.1 | 2.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.1 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.1 | 0.4 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.1 | 0.4 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.1 | 0.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.6 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 0.1 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.1 | 0.4 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.1 | 1.0 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.4 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 1.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 1.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.4 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.1 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.1 | 0.1 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.3 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.1 | 0.4 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.1 | 1.2 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.3 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 1.2 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 0.3 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.1 | 1.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.1 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 1.3 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.1 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.1 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 0.4 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 1.8 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.1 | 0.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.1 | 0.3 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.1 | 0.1 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.3 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 0.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 1.3 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.1 | 0.4 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.8 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.1 | 0.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.3 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 0.5 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.4 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 1.9 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.1 | GO:2000679 | positive regulation of transcription regulatory region DNA binding(GO:2000679) |
0.1 | 0.7 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 2.6 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 0.2 | GO:0097421 | liver regeneration(GO:0097421) |
0.1 | 0.6 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.4 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.9 | GO:0048753 | pigment granule organization(GO:0048753) |
0.1 | 0.7 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.2 | GO:0002374 | cytokine secretion involved in immune response(GO:0002374) |
0.1 | 0.6 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.2 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.1 | 0.6 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.4 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.2 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.1 | 0.2 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.5 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 0.4 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 2.7 | GO:0038034 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
0.1 | 0.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 1.5 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 0.2 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.1 | 2.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.1 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 0.3 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.7 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.2 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.3 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.8 | GO:0001707 | mesoderm formation(GO:0001707) |
0.1 | 0.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.3 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.1 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.3 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.8 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.1 | 0.8 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.3 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.2 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 1.1 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.8 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.1 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 0.1 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.1 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.4 | GO:0071216 | cellular response to biotic stimulus(GO:0071216) |
0.1 | 0.3 | GO:0060065 | uterus development(GO:0060065) |
0.1 | 0.1 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.1 | 0.2 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.2 | GO:0045414 | regulation of interleukin-8 biosynthetic process(GO:0045414) |
0.1 | 0.1 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.1 | 0.1 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.1 | 0.1 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.1 | 9.2 | GO:0071219 | cellular response to molecule of bacterial origin(GO:0071219) |
0.1 | 0.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.5 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.1 | 0.8 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 0.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 0.3 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 0.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 0.8 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.1 | 1.1 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.5 | GO:0033273 | response to vitamin(GO:0033273) |
0.1 | 0.6 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 0.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.2 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.1 | 0.3 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.1 | 0.3 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 1.4 | GO:0071621 | granulocyte chemotaxis(GO:0071621) |
0.1 | 0.1 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.1 | 0.5 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.2 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.3 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 0.4 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.3 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.1 | 1.7 | GO:0007569 | cell aging(GO:0007569) |
0.1 | 0.2 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.1 | 0.9 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.4 | GO:0034397 | telomere localization(GO:0034397) |
0.1 | 0.1 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.1 | 0.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.6 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.2 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 0.6 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 2.5 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 0.2 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.1 | 0.3 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.1 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.1 | 0.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 0.8 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.1 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.1 | 0.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.2 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.1 | 1.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.1 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.6 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.1 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
0.1 | 0.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.2 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 1.8 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.1 | 0.2 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.8 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 1.5 | GO:0052696 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.1 | 0.1 | GO:0015867 | ATP transport(GO:0015867) |
0.1 | 0.1 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.1 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.1 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.6 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.3 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.3 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.1 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.3 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.1 | 0.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.1 | 0.2 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.6 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 1.0 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 0.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.1 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.1 | 0.7 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.1 | 0.3 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 1.0 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.2 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.1 | 0.3 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.1 | 0.1 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.1 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.1 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.1 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 1.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.4 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.5 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.1 | 0.3 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.1 | 0.5 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.1 | 0.4 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.1 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.1 | 0.1 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.1 | 0.2 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.2 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.2 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 1.0 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.7 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.2 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.1 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.1 | 1.1 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.1 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.1 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.1 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 0.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.1 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.9 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.1 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.2 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.2 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 0.2 | GO:0042255 | ribosome assembly(GO:0042255) |
0.1 | 0.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.4 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.1 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 1.1 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 1.1 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.2 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.1 | 0.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.1 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.1 | 2.3 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 1.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.1 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.1 | 0.1 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 0.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.0 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.0 | 1.7 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.0 | 0.0 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 1.9 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.0 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.0 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.0 | 0.3 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.1 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
0.0 | 0.3 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.3 | GO:0045621 | positive regulation of lymphocyte differentiation(GO:0045621) |
0.0 | 0.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.6 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.0 | 0.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 1.0 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.4 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.0 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.0 | 0.2 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.0 | 0.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.0 | 0.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.5 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.0 | 0.1 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.2 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 0.0 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.2 | GO:0090199 | regulation of release of cytochrome c from mitochondria(GO:0090199) |
0.0 | 0.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.2 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.0 | 0.8 | GO:0042476 | odontogenesis(GO:0042476) |
0.0 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.0 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.0 | 2.7 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.0 | GO:0030576 | Cajal body organization(GO:0030576) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.0 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
0.0 | 0.2 | GO:0042108 | positive regulation of cytokine biosynthetic process(GO:0042108) |
0.0 | 0.4 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.3 | GO:0010965 | regulation of mitotic sister chromatid separation(GO:0010965) |
0.0 | 0.3 | GO:2001242 | regulation of intrinsic apoptotic signaling pathway(GO:2001242) |
0.0 | 0.2 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.0 | 0.2 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.0 | 0.2 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.0 | 0.1 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 0.1 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.0 | 0.3 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.0 | 0.2 | GO:0070633 | transepithelial transport(GO:0070633) |
0.0 | 0.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.0 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.0 | 0.1 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0002504 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 0.0 | GO:0002063 | chondrocyte development(GO:0002063) |
0.0 | 0.1 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.4 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.4 | GO:1901184 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) regulation of ERBB signaling pathway(GO:1901184) |
0.0 | 0.5 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.0 | GO:0035977 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.0 | 0.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.1 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.0 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.1 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.0 | 0.1 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.0 | 0.1 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.0 | 0.1 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 0.4 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.0 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.0 | 0.0 | GO:0046490 | negative regulation of cholesterol biosynthetic process(GO:0045541) isopentenyl diphosphate metabolic process(GO:0046490) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.0 | GO:1904036 | negative regulation of epithelial cell apoptotic process(GO:1904036) |
0.0 | 0.1 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 0.0 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.0 | 0.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 0.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.1 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 0.3 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.0 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.0 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.0 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.0 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.0 | 0.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.9 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
2.0 | 7.9 | GO:0071953 | elastic fiber(GO:0071953) |
1.7 | 5.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
1.7 | 19.8 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.3 | 6.6 | GO:0008091 | spectrin(GO:0008091) |
1.3 | 2.5 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.3 | 3.8 | GO:0005914 | spot adherens junction(GO:0005914) |
1.2 | 8.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.1 | 4.4 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.1 | 6.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
1.0 | 3.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
1.0 | 5.0 | GO:0031983 | vesicle lumen(GO:0031983) |
1.0 | 7.9 | GO:0005861 | troponin complex(GO:0005861) |
1.0 | 3.9 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
1.0 | 3.9 | GO:0097452 | GAIT complex(GO:0097452) |
1.0 | 1.9 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.9 | 3.8 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.9 | 0.9 | GO:0055087 | Ski complex(GO:0055087) |
0.9 | 1.8 | GO:0044393 | microspike(GO:0044393) |
0.9 | 2.7 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.9 | 8.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.9 | 6.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.8 | 2.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.8 | 3.3 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.8 | 4.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.7 | 3.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.7 | 2.2 | GO:0097427 | microtubule bundle(GO:0097427) |
0.7 | 3.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.7 | 3.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.7 | 4.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.7 | 2.9 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.7 | 5.0 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.7 | 2.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.7 | 0.7 | GO:0043219 | lateral loop(GO:0043219) |
0.7 | 2.7 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.7 | 10.1 | GO:0031430 | M band(GO:0031430) |
0.7 | 2.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.6 | 5.8 | GO:0097542 | ciliary tip(GO:0097542) |
0.6 | 2.6 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.6 | 2.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.6 | 1.9 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.6 | 1.9 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.6 | 4.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.6 | 1.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.6 | 210.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.6 | 2.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.6 | 1.8 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.6 | 9.5 | GO:0002102 | podosome(GO:0002102) |
0.6 | 2.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.6 | 2.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.6 | 2.9 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.6 | 28.7 | GO:0032432 | actin filament bundle(GO:0032432) |
0.6 | 9.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.6 | 4.5 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.6 | 1.7 | GO:0005915 | zonula adherens(GO:0005915) |
0.6 | 1.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.5 | 2.2 | GO:0005642 | annulate lamellae(GO:0005642) |
0.5 | 3.8 | GO:0005688 | U6 snRNP(GO:0005688) |
0.5 | 0.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.5 | 31.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.5 | 1.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.5 | 1.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.5 | 2.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.5 | 1.0 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.5 | 4.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.5 | 1.0 | GO:0097443 | sorting endosome(GO:0097443) |
0.5 | 3.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.5 | 1.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.5 | 1.5 | GO:1990423 | RZZ complex(GO:1990423) |
0.5 | 3.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 1.5 | GO:1990393 | 3M complex(GO:1990393) |
0.5 | 7.0 | GO:0043034 | costamere(GO:0043034) |
0.5 | 4.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.5 | 5.3 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.5 | 2.4 | GO:0005638 | lamin filament(GO:0005638) |
0.5 | 1.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.5 | 1.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.5 | 1.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.5 | 3.7 | GO:0036157 | outer dynein arm(GO:0036157) |
0.5 | 2.8 | GO:0090543 | Flemming body(GO:0090543) |
0.5 | 1.4 | GO:0045180 | basal cortex(GO:0045180) |
0.5 | 2.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 1.4 | GO:0097342 | ripoptosome(GO:0097342) |
0.5 | 0.9 | GO:0099738 | cell cortex region(GO:0099738) |
0.5 | 0.5 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.4 | 5.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.4 | 3.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.4 | 4.4 | GO:0001527 | microfibril(GO:0001527) |
0.4 | 2.2 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.4 | 2.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.4 | 5.6 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.4 | 3.9 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.4 | 1.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.4 | 0.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.4 | 5.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 1.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.4 | 1.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.4 | 1.6 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.4 | 1.6 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.4 | 2.8 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.4 | 1.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.4 | 1.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.4 | 1.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.4 | 15.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.4 | 1.2 | GO:0030478 | actin cap(GO:0030478) |
0.4 | 1.9 | GO:0001940 | male pronucleus(GO:0001940) |
0.4 | 0.8 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.4 | 3.1 | GO:0045179 | apical cortex(GO:0045179) |
0.4 | 10.6 | GO:0016235 | aggresome(GO:0016235) |
0.4 | 7.2 | GO:0008305 | integrin complex(GO:0008305) |
0.4 | 1.5 | GO:0042825 | TAP complex(GO:0042825) |
0.4 | 1.9 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 3.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.4 | 1.5 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.4 | 1.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.4 | 0.4 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.4 | 1.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.4 | 1.4 | GO:1990130 | Iml1 complex(GO:1990130) |
0.4 | 0.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.4 | 1.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.4 | 1.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.4 | 1.4 | GO:0001650 | fibrillar center(GO:0001650) |
0.4 | 4.2 | GO:0045120 | pronucleus(GO:0045120) |
0.4 | 4.6 | GO:0010369 | chromocenter(GO:0010369) |
0.4 | 1.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.3 | 3.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.3 | 22.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 1.4 | GO:0035339 | SPOTS complex(GO:0035339) |
0.3 | 0.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 1.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.3 | 13.2 | GO:0045095 | keratin filament(GO:0045095) |
0.3 | 1.7 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.3 | 3.6 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 1.6 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.3 | 8.4 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.3 | 1.0 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.3 | 1.0 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.3 | 4.1 | GO:0031672 | A band(GO:0031672) |
0.3 | 0.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.3 | 1.3 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.3 | 3.8 | GO:0043218 | compact myelin(GO:0043218) |
0.3 | 0.9 | GO:0042827 | platelet dense granule(GO:0042827) |
0.3 | 3.9 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.3 | 3.0 | GO:0033391 | chromatoid body(GO:0033391) |
0.3 | 2.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 0.6 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.3 | 21.0 | GO:0005604 | basement membrane(GO:0005604) |
0.3 | 3.2 | GO:0042581 | specific granule(GO:0042581) |
0.3 | 0.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.3 | 14.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 1.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 2.6 | GO:0036128 | CatSper complex(GO:0036128) |
0.3 | 0.6 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.3 | 1.4 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 63.8 | GO:0005925 | focal adhesion(GO:0005925) |
0.3 | 4.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.3 | 3.1 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 0.8 | GO:0071564 | npBAF complex(GO:0071564) |
0.3 | 2.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 0.8 | GO:0072687 | meiotic spindle(GO:0072687) |
0.3 | 2.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.3 | 0.8 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 1.0 | GO:0000938 | GARP complex(GO:0000938) |
0.3 | 0.3 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.3 | 0.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.3 | 2.0 | GO:0071439 | clathrin complex(GO:0071439) |
0.3 | 1.0 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.3 | 2.0 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.3 | 0.8 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 5.5 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 15.7 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.2 | 1.5 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 0.5 | GO:0008278 | cohesin complex(GO:0008278) |
0.2 | 1.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 4.1 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.9 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 0.9 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 0.5 | GO:0070069 | cytochrome complex(GO:0070069) |
0.2 | 2.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 46.9 | GO:0031012 | extracellular matrix(GO:0031012) |
0.2 | 0.7 | GO:0035061 | interchromatin granule(GO:0035061) |
0.2 | 3.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 0.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.2 | 4.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 0.9 | GO:0042627 | chylomicron(GO:0042627) |
0.2 | 2.8 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 1.5 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 0.4 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.2 | 3.9 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 1.9 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 3.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 0.4 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 0.2 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.2 | 6.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 0.6 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
0.2 | 1.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 9.0 | GO:0016605 | PML body(GO:0016605) |
0.2 | 8.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 0.6 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 8.4 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 0.6 | GO:0030689 | Noc complex(GO:0030689) |
0.2 | 1.7 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 1.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 0.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 1.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 1.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 0.5 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 0.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 1.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 0.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 0.7 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 3.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 3.8 | GO:0031902 | late endosome membrane(GO:0031902) |
0.2 | 0.7 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 1.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 0.2 | GO:0097526 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.2 | 0.9 | GO:0000243 | commitment complex(GO:0000243) |
0.2 | 3.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 0.3 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 0.8 | GO:0000803 | sex chromosome(GO:0000803) |
0.2 | 1.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 0.5 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 1.8 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 0.2 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 0.2 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.2 | 5.0 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 0.6 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 0.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 3.0 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 0.5 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 1.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 4.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 2.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.6 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 1.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.4 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 3.4 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 0.3 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 0.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.5 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 2.6 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 3.4 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.5 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 0.7 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 0.5 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 1.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.4 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 15.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.5 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 6.3 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 3.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.1 | 0.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.6 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 2.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 2.6 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.4 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 7.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.2 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.1 | 1.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.5 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 11.5 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 1.5 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 3.9 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 8.2 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.4 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 0.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.4 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 2.3 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.1 | 4.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 4.6 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.8 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.5 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 5.9 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 1.0 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 22.8 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 1.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.5 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.1 | 0.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 3.1 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.1 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.1 | 0.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.2 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 1.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.4 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.7 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.6 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 76.4 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 53.5 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 4.1 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 1.9 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.1 | 0.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.4 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.2 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.6 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.1 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.0 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 0.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.4 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 1.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 1.2 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 0.0 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 2.0 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.1 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.2 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.0 | 0.1 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.0 | 0.1 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.1 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 8.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
2.7 | 16.5 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
2.4 | 12.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
2.2 | 26.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
2.0 | 6.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.9 | 7.6 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.9 | 5.6 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
1.8 | 5.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
1.7 | 10.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
1.6 | 4.9 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.6 | 9.8 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.6 | 1.6 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
1.5 | 7.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.5 | 16.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.5 | 1.5 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.5 | 6.1 | GO:0005534 | galactose binding(GO:0005534) |
1.5 | 4.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.5 | 7.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
1.5 | 2.9 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.4 | 8.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.4 | 4.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.3 | 3.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.3 | 3.8 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.2 | 3.7 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.2 | 9.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.2 | 4.6 | GO:1990715 | mRNA CDS binding(GO:1990715) |
1.1 | 4.5 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.1 | 1.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
1.1 | 4.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
1.1 | 4.3 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.1 | 38.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
1.0 | 1.0 | GO:0035939 | microsatellite binding(GO:0035939) |
1.0 | 3.0 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
1.0 | 3.0 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.0 | 3.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.9 | 3.8 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.9 | 2.8 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.9 | 2.8 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.9 | 4.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.9 | 2.8 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.9 | 3.7 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.9 | 4.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.9 | 2.8 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.9 | 12.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.9 | 10.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.9 | 2.7 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.9 | 6.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.9 | 2.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.9 | 2.6 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.9 | 2.6 | GO:0030172 | troponin C binding(GO:0030172) |
0.9 | 4.3 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.8 | 2.4 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.8 | 7.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.8 | 6.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.8 | 3.2 | GO:0009374 | biotin binding(GO:0009374) |
0.8 | 2.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.8 | 3.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.8 | 2.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.8 | 2.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.8 | 3.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.8 | 3.9 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.8 | 3.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.8 | 9.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.8 | 2.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.8 | 2.3 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.8 | 3.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.8 | 2.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.8 | 2.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.8 | 25.6 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.8 | 2.3 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.7 | 0.7 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.7 | 6.6 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.7 | 1.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.7 | 0.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.7 | 5.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.7 | 3.6 | GO:0016936 | galactoside binding(GO:0016936) |
0.7 | 2.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.7 | 2.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.7 | 2.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.7 | 5.6 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.7 | 55.7 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.7 | 2.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.7 | 4.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.7 | 0.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.7 | 2.0 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.7 | 2.6 | GO:0034618 | arginine binding(GO:0034618) |
0.7 | 2.6 | GO:0015265 | urea channel activity(GO:0015265) |
0.7 | 2.0 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.7 | 3.9 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.6 | 3.2 | GO:0070888 | E-box binding(GO:0070888) |
0.6 | 1.3 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.6 | 3.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.6 | 1.9 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.6 | 9.6 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.6 | 5.8 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.6 | 5.1 | GO:0038191 | neuropilin binding(GO:0038191) |
0.6 | 3.8 | GO:0039706 | co-receptor binding(GO:0039706) |
0.6 | 5.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.6 | 0.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.6 | 1.9 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.6 | 1.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.6 | 11.0 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.6 | 2.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.6 | 2.4 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.6 | 1.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.6 | 1.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.6 | 1.8 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.6 | 1.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.6 | 1.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.6 | 2.9 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.6 | 3.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.6 | 20.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.6 | 5.7 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.6 | 5.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.6 | 3.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.6 | 6.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.6 | 1.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.6 | 2.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.6 | 1.7 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.6 | 1.7 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.6 | 2.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.6 | 1.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.5 | 2.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.5 | 5.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.5 | 8.1 | GO:0008143 | poly(A) binding(GO:0008143) |
0.5 | 2.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.5 | 9.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.5 | 1.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.5 | 2.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.5 | 2.7 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.5 | 2.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.5 | 1.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.5 | 1.6 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.5 | 6.8 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.5 | 49.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.5 | 9.9 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.5 | 1.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.5 | 1.5 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.5 | 9.8 | GO:0001968 | fibronectin binding(GO:0001968) |
0.5 | 1.5 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.5 | 3.6 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.5 | 2.0 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.5 | 1.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.5 | 1.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.5 | 3.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.5 | 3.5 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.5 | 0.5 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.5 | 2.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.5 | 1.0 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.5 | 3.4 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.5 | 2.4 | GO:0071253 | connexin binding(GO:0071253) |
0.5 | 1.9 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.5 | 0.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.5 | 2.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.5 | 2.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.5 | 2.4 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.5 | 1.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.5 | 1.9 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.5 | 2.3 | GO:0005113 | patched binding(GO:0005113) |
0.5 | 1.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.5 | 1.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.5 | 0.9 | GO:0019862 | IgA binding(GO:0019862) |
0.5 | 1.4 | GO:0031433 | telethonin binding(GO:0031433) |
0.5 | 1.8 | GO:0045545 | syndecan binding(GO:0045545) |
0.5 | 1.8 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.4 | 1.3 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.4 | 5.8 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.4 | 0.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.4 | 2.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.4 | 4.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.4 | 3.1 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.4 | 1.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.4 | 7.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.4 | 3.9 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.4 | 3.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.4 | 2.6 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.4 | 2.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.4 | 0.9 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.4 | 0.4 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.4 | 3.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.4 | 1.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.4 | 1.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.4 | 1.3 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.4 | 2.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.4 | 2.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.4 | 1.7 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.4 | 2.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.4 | 4.9 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.4 | 2.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.4 | 5.7 | GO:0005123 | death receptor binding(GO:0005123) |
0.4 | 3.3 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.4 | 1.2 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.4 | 0.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.4 | 7.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 5.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.4 | 2.0 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.4 | 1.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.4 | 4.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.4 | 0.4 | GO:0051373 | FATZ binding(GO:0051373) |
0.4 | 14.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.4 | 4.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.4 | 0.4 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.4 | 1.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.4 | 1.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.4 | 1.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.4 | 14.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.4 | 3.5 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.4 | 2.7 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.4 | 1.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.4 | 1.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.4 | 1.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.4 | 5.0 | GO:0043236 | laminin binding(GO:0043236) |
0.4 | 1.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.4 | 2.3 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.4 | 2.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 1.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.4 | 3.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.4 | 0.4 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.4 | 1.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.4 | 2.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.4 | 3.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.4 | 0.4 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.4 | 2.9 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.4 | 3.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.4 | 3.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.4 | 0.4 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.4 | 26.7 | GO:0005178 | integrin binding(GO:0005178) |
0.4 | 2.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.4 | 4.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.4 | 1.4 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.4 | 2.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.4 | 2.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.4 | 0.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.4 | 1.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 7.4 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.4 | 1.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.3 | 11.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.3 | 2.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 4.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 0.7 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.3 | 0.7 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 1.0 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.3 | 1.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.3 | 0.3 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.3 | 1.4 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 1.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 1.0 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.3 | 2.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 3.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 2.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.3 | 1.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 1.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 3.6 | GO:0035198 | miRNA binding(GO:0035198) |
0.3 | 4.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 1.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 0.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 1.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.3 | 1.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 1.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.3 | 1.0 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.3 | 0.6 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 1.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.3 | 1.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 0.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.3 | 1.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.3 | 5.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 0.9 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.3 | 4.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.3 | 0.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 0.6 | GO:0036033 | mediator complex binding(GO:0036033) |
0.3 | 7.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.3 | 1.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 66.5 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.3 | 1.2 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.3 | 0.9 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 3.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.3 | 1.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.3 | 1.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 1.5 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.3 | 8.7 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.3 | 8.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.3 | 1.5 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 0.9 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.3 | 1.2 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.3 | 0.9 | GO:0035326 | enhancer binding(GO:0035326) |
0.3 | 1.8 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 1.5 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.3 | 0.6 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.3 | 1.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.3 | 0.9 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 0.9 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.3 | 0.6 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.3 | 0.8 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.3 | 0.8 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.3 | 2.8 | GO:0005542 | folic acid binding(GO:0005542) |
0.3 | 0.8 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.3 | 1.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 0.6 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.3 | 3.3 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.3 | 1.9 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.3 | 2.5 | GO:0035173 | histone kinase activity(GO:0035173) |
0.3 | 1.1 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.3 | 0.5 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.3 | 0.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.3 | 0.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.3 | 0.3 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.3 | 4.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.3 | 0.8 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.3 | 2.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 0.3 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
0.3 | 0.8 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.3 | 0.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.3 | 1.0 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.3 | 1.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 2.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 0.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 13.0 | GO:0001047 | core promoter binding(GO:0001047) |
0.3 | 1.0 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.3 | 0.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.3 | 0.8 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.3 | 0.3 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.3 | 0.8 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.3 | 0.8 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.3 | 0.8 | GO:0019002 | GMP binding(GO:0019002) |
0.3 | 1.5 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.3 | 0.8 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 4.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 0.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.2 | 4.0 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.2 | 1.0 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 1.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 2.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 1.0 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 0.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 0.7 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.2 | 0.7 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 0.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 1.7 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.2 | 0.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 0.7 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.2 | 1.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 1.4 | GO:0034809 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.2 | 1.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 0.9 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 0.7 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.2 | 0.9 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 0.7 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 7.0 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 0.9 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 1.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 8.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.2 | 0.7 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 0.7 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 0.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 0.9 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.7 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 3.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 1.5 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 0.9 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 0.9 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 4.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 1.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 1.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 2.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.2 | 1.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 1.7 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 2.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 0.8 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 0.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 1.0 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 1.8 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 0.8 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.2 | 1.0 | GO:0070061 | fructose binding(GO:0070061) |
0.2 | 0.2 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 0.2 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.2 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.2 | 1.4 | GO:0034901 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 1.6 | GO:0046977 | TAP binding(GO:0046977) |
0.2 | 2.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 1.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 0.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 0.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 1.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.2 | 0.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 4.5 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.2 | 2.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 1.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 0.9 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 0.2 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.2 | 5.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 0.7 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 0.7 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.2 | 1.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 0.9 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 58.0 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.2 | 1.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.2 | 32.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 0.5 | GO:0030546 | receptor activator activity(GO:0030546) |
0.2 | 0.2 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.2 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.2 | 0.5 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 1.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 0.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 9.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 0.7 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.7 | GO:0050544 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.2 | 1.4 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 1.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.2 | 0.2 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.2 | 1.0 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.2 | 0.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 1.0 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 0.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 0.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 0.7 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 0.8 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 0.8 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 0.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 0.2 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.2 | 0.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 17.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 0.5 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 1.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 7.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 0.5 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 0.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 0.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 0.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 1.7 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.2 | 0.2 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.2 | 1.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.2 | 0.9 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 0.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 1.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 1.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.7 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.1 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.1 | 1.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.1 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.6 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 0.9 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.1 | 0.4 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 1.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 1.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 1.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 1.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 22.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 1.0 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 1.7 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 0.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.1 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 1.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.1 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.8 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 1.2 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 1.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.7 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.6 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 0.5 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 3.1 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 0.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.1 | 0.3 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.2 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 2.9 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 3.6 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.8 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.8 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 4.2 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 0.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 2.0 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.7 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 0.4 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 2.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.8 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.3 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 0.1 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.1 | 1.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.5 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.1 | 0.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 2.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 0.4 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.4 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 0.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.7 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.4 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.4 | GO:0004953 | icosanoid receptor activity(GO:0004953) leukotriene receptor activity(GO:0004974) |
0.1 | 0.1 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.3 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.1 | 3.4 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.2 | GO:0080014 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) phenanthrene 9,10-monooxygenase activity(GO:0018636) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.1 | 0.2 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.1 | 0.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.3 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.1 | 2.2 | GO:0005126 | cytokine receptor binding(GO:0005126) |
0.1 | 0.5 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.3 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 1.1 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.1 | 12.2 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 1.1 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.6 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.1 | 0.3 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 6.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.0 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 3.3 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.1 | 1.3 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 0.7 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 3.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.4 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
0.1 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 2.9 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 1.9 | GO:0019955 | cytokine binding(GO:0019955) |
0.1 | 0.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 5.6 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.1 | 0.6 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.6 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.1 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
0.1 | 0.1 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 0.6 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 0.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.5 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.9 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 1.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.9 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.1 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.4 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 1.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.8 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.3 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.1 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 2.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 3.6 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.5 | GO:0010857 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 1.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.3 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.1 | GO:0032564 | dATP binding(GO:0032564) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 0.3 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 0.1 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 1.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 3.7 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 1.2 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 0.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.0 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 0.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.4 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.7 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 6.0 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.1 | GO:0050051 | alkane 1-monooxygenase activity(GO:0018685) leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.0 | 0.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.5 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.4 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.0 | 0.2 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 2.3 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.0 | 0.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 1.1 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.0 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.1 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 14.4 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.1 | GO:0070717 | poly(G) binding(GO:0034046) poly-purine tract binding(GO:0070717) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 0.1 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 0.1 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.0 | 0.0 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 1.4 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.0 | 0.5 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.2 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.0 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.0 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.0 | 0.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.3 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.0 | GO:0018561 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.0 | 0.1 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.0 | 0.0 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.0 | 0.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.0 | 0.3 | GO:0020037 | heme binding(GO:0020037) |
0.0 | 0.1 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.0 | 0.3 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.0 | 0.1 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.0 | 0.0 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 2.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.1 | 47.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.0 | 44.8 | NABA COLLAGENS | Genes encoding collagen proteins |
1.0 | 10.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.9 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.9 | 1.7 | ST STAT3 PATHWAY | STAT3 Pathway |
0.8 | 22.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.8 | 4.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.8 | 5.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.7 | 15.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.7 | 29.2 | PID BMP PATHWAY | BMP receptor signaling |
0.7 | 18.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.7 | 28.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.7 | 1.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.7 | 6.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.6 | 28.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.6 | 15.4 | ST GAQ PATHWAY | G alpha q Pathway |
0.6 | 11.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.6 | 4.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.6 | 31.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.6 | 9.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.6 | 29.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.5 | 6.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.5 | 7.0 | PID ALK1 PATHWAY | ALK1 signaling events |
0.5 | 4.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.5 | 12.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.5 | 2.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.5 | 10.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.5 | 4.9 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.5 | 11.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.5 | 14.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.5 | 8.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.5 | 4.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.5 | 7.8 | PID EPO PATHWAY | EPO signaling pathway |
0.4 | 10.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.4 | 15.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.4 | 7.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.4 | 10.3 | PID FGF PATHWAY | FGF signaling pathway |
0.4 | 16.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.4 | 0.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 0.4 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.4 | 3.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.4 | 4.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 1.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.4 | 0.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 13.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.4 | 5.4 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.4 | 7.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.4 | 1.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.4 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 6.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.4 | 0.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 11.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 4.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 0.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 1.3 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 3.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 0.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 0.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 5.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.3 | 14.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 1.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 7.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.3 | 2.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 4.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 3.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.3 | 4.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 9.7 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 3.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 2.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.3 | 7.7 | PID E2F PATHWAY | E2F transcription factor network |
0.3 | 0.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 0.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 6.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 2.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 1.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 4.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 34.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 3.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 42.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 1.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 4.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 0.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 1.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 0.6 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 4.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 3.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 2.0 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 1.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 3.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 0.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 2.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 1.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 0.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 2.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 7.8 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.2 | 1.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 2.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 5.9 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 1.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 1.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 0.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 1.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 3.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.2 | 0.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 0.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 1.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.8 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 1.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 3.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 3.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 2.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 6.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 1.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.9 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 11.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 0.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 7.1 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.0 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 1.9 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
1.8 | 1.8 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
1.7 | 24.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.0 | 9.9 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
1.0 | 1.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
1.0 | 51.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
1.0 | 21.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.0 | 16.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.9 | 21.1 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.9 | 1.8 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.9 | 20.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.8 | 1.6 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.8 | 8.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.8 | 3.8 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.7 | 10.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.7 | 2.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.7 | 7.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.6 | 0.6 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.6 | 11.7 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.6 | 3.6 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.6 | 1.2 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.6 | 16.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.6 | 1.2 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.6 | 0.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.6 | 5.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.6 | 6.2 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.5 | 15.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.5 | 13.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.5 | 5.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.5 | 5.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.5 | 6.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.5 | 1.0 | REACTOME PI 3K CASCADE | Genes involved in PI-3K cascade |
0.5 | 5.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.5 | 8.7 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.5 | 1.4 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.5 | 0.5 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.5 | 9.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.5 | 36.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.5 | 4.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.4 | 3.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 12.0 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.4 | 3.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.4 | 6.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.4 | 1.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.4 | 7.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.4 | 4.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.4 | 9.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.4 | 3.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.4 | 3.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.4 | 3.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.4 | 5.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.4 | 2.0 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.4 | 5.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.4 | 3.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.4 | 1.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.4 | 0.4 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.4 | 0.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.4 | 14.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.4 | 3.2 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.3 | 2.7 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.3 | 2.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 1.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 3.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.3 | 3.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 3.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.3 | 8.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 3.9 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.3 | 1.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.3 | 2.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 0.9 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.3 | 3.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.3 | 5.9 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.3 | 6.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.3 | 3.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.3 | 0.9 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.3 | 8.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.3 | 1.4 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.3 | 2.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 2.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.3 | 8.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 2.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 4.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 1.4 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.3 | 24.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 4.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 1.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 3.6 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.3 | 2.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 3.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 2.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 0.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 4.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 3.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 0.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 1.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 10.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 1.4 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.2 | 2.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.2 | 1.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.2 | 2.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 23.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 7.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 14.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 2.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 3.1 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 2.6 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 10.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 0.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 20.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 0.2 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.2 | 1.5 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 0.2 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.2 | 2.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 0.5 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.2 | 1.1 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.2 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 2.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 2.3 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.2 | 0.7 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.2 | 0.7 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 2.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 1.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 6.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 3.0 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 1.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 1.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 2.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 5.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.3 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 8.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 2.1 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 1.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.4 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 2.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 1.7 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 1.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.8 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 1.0 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 1.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.2 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 1.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 2.1 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 2.4 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.1 | 2.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.1 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.1 | 1.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 1.0 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 1.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 1.1 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 1.0 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.1 | 1.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.3 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.9 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 0.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 1.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 3.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.1 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 0.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 5.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 1.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 2.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 0.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 0.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 1.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 1.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.5 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.0 | 0.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 1.7 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.0 | 0.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.5 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.0 | 0.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |